Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”
ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number
Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board
GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System
FDA Updates Safety Information for 5-Alpha Reductase Inhibitors
ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years
Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









